40 Participants NeededMy employer runs this trial

Topical Steroids for UTI Prevention in Infants

(STRUMI-T Trial)

Recruiting at 2 trial locations
SW
Overseen BySowdhamini Wallace, DO, MS
Age: < 18
Sex: Male
Trial Phase: Phase 4
Sponsor: Baylor College of Medicine
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests whether a steroid cream (Betamethasone Valerate) can prevent urinary tract infections (UTIs) in uncircumcised male infants. Infants in the study will receive either the steroid cream or a placebo cream that looks identical but contains no active ingredients. The cream is applied twice a week for four weeks, followed by check-ups to assess its effectiveness in preventing UTIs. Uncircumcised male infants under six months old who have experienced a doctor-confirmed UTI with symptoms like fever may qualify for this study. As a Phase 4 trial, this research aims to understand how the already FDA-approved and effective treatment benefits a broader patient population.

Do I have to stop my baby's current medications for this trial?

The trial information does not specify whether you need to stop your baby's current medications. It's best to discuss this with the research team.

What is the safety track record for Betamethasone Valerate?

Past research has used Betamethasone Valerate, a steroid cream, to treat skin issues like redness and swelling. Studies have shown that it is generally safe when used as directed, with serious side effects being rare. Most side effects involve mild skin irritation, such as itching or redness at the application site, and these usually resolve on their own.

The FDA has already approved the treatment for other uses, indicating its general safety. This trial is in a later stage, suggesting strong evidence of the treatment's safety for people. However, following all guidelines provided during the trial is important to minimize potential risks.12345

Why are researchers enthusiastic about this study treatment?

Most treatments for urinary tract infections (UTIs) in infants involve antibiotics, which can lead to resistance and other side effects. Betamethasone Valerate, the treatment under study, is unique because it uses a topical steroid cream that can be applied directly to the skin, potentially reducing the risk of UTIs without systemic exposure. Researchers are excited about this treatment because it offers a non-invasive alternative that could help prevent UTIs while minimizing the use of antibiotics. This approach could be a game-changer in managing infant UTIs, offering a targeted preventative measure with fewer side effects.

What evidence suggests that this treatment might be an effective treatment for urinary tract infections?

Research has shown that using a steroid cream, such as Betamethasone Valerate, can reduce the risk of repeated urinary tract infections (UTIs) in uncircumcised baby boys. One study found that applying this cream to treat phimosis—a condition where the foreskin is too tight to retract—resulted in fewer UTIs in these infants. This trial will compare the effects of Betamethasone Valerate cream with a placebo cream to evaluate its effectiveness in preventing UTIs. The evidence supports the potential of steroid cream as a preventive measure for UTIs in this group.678910

Are You a Good Fit for This Trial?

This trial is for uncircumcised male infants under 6 months old who have had their first urinary tract infection confirmed by a doctor and lab tests. Infants must not have certain penile abnormalities, allergies to steroid creams, or prior use of topical steroids.

Inclusion Criteria

Fever (temperature ≥38.0 C) or hypothermia (temperature <36.0 C) per ED/hospitalization or parental report
I am an uncircumcised male infant younger than 6 months old.
I have had my first UTI confirmed by my doctor and lab tests.

Exclusion Criteria

Legal guardian not available to provide informed consent
Infant in Child Protective Services (CPS) custody
I have been diagnosed with a penile abnormality such as epispadius, hypospadias, or chordee.
See 7 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

up to 2 weeks

Treatment

Participants receive either the steroid cream or placebo cream applied twice a week for four weeks

4 weeks
2 visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment, including measuring urinary tract infections and parent perceptions

6 months
2 visits (in-person)

What Are the Treatments Tested in This Trial?

Interventions

  • Betamethasone Valerate

Trial Overview

The study compares a steroid cream (betamethasone valerate 0.1%) with a placebo cream applied twice weekly for four weeks to see if the steroid can help prevent more urinary tract infections in these infants.

How Is the Trial Designed?

2

Treatment groups

Active Control

Placebo Group

Group I: Participants randomized to receive steroid creamActive Control1 Intervention
Group II: Participants randomized to receive placebo cream.Placebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Baylor College of Medicine

Lead Sponsor

Trials
1,044
Recruited
6,031,000+

Seattle Children's Hospital

Collaborator

Trials
319
Recruited
5,232,000+

Citations

Topical Steroids to Prevent Recurrent Urinary Tract ...

Male infants, who are enrolled in this study, would receive either the steroid cream or a placebo cream (a look alike cream without steroids).

Phimosis Treatment and Recurrent Urinary Tract Infection ...

Conclusion: The use of steroid cream for physiologic phimosis is associated with a decreased risk of recurrent UTIs in uncircumcised male ...

The use of steroid cream for physiologic phimosis in male ...

The use of steroid cream for physiologic phimosis is associated with a decreased risk of recurrent UTIs in uncircumcised male in- fants with a ...

4.

pubmed.ncbi.nlm.nih.gov

pubmed.ncbi.nlm.nih.gov/31345734/

The Use of Steroid Cream for Physiologic Phimosis in Male ...

Conclusion: The use of steroid cream for physiologic phimosis is associated with a decreased risk of recurrent UTIs in uncircumcised male infants with a normal ...

Trial finds limited benefit from continuous antibiotic ...

In the intention-to-treat analysis, 31 infants (21.2%) in the prophylaxis group developed a first UTI, compared with 52 (35.6%) in the untreated ...

Review of non-antibiotic treatment and prevention of recurrent ...

The lifetime prevalence of at least one symptomatic UTI in women is estimated to exceed 50%, with 20%–40% experiencing recurrent UTIs (rUTIs).

208079Orig1s000 - accessdata.fda.gov

Parallel Group Study of the Efficacy and Safety of Betamethasone Dipropionate ... and moderate urinary tract infection on Day 26. None were considered related ...

Prevention of Recurrent Urinary Tract Infection in Women

Results showed a significant 51.9% reduction in UTI frequency in the year following prescription, with 55.3% of patients experiencing ≤1 UTI and ...

Betamethasone dipropionate Medicare coverage

Betamethasone is a potent (strong) medication used to relieve the inflammation (redness, swelling, warmth, pain) and itching from different skin conditions.

Recurrent Urinary Tract Infections - StatPearls - NCBI Bookshelf

The oral vaccine, MV140, has shown good efficacy in preventing recurrent UTIs in several studies with safety data and minimal adverse effects. A preliminary ...